Skip to main content

Nanoviricides, Inc.

NNVC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001379006

No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Nanoviricides, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of NNVC: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders3543+8
Shares1.43M3.11M+1.68M (+117.3%)
Value$2.04M$3.51M+$1.47M (+71.7%)

New holders (11)

Institutions that held Nanoviricides, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to NNVC in Q4 2025
InstitutionSharesValue% of portfolio
Armistice Capital, LLC1,368,000$1.55M0.04%
Jane Street Group, LLC124,068$140.2K0.00%
Miller Financial Services LLC72,000$81.4K0.10%
Two Sigma Securities, LLC17,211$19.4K0.00%
EFG International AG4,500$5.08K0.00%
Jones Financial Companies LLLP3,000$3.39K0.00%
Curio Wealth, LLC2,000$2.38K0.00%
Sittner & Nelson, LLC1,000$8800.00%
DecisionPoint Financial, LLC50$570.00%
National Bank of Canada50$560.00%
Northwestern Mutual Wealth Management Co35$400.00%

Sold out (3)

Institutions that held Nanoviricides, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of NNVC in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Advisory Services Network, LLC3,000$4.29K
SBI Securities Co., Ltd.300$429
FMR LLC36$51